{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:28:42Z","timestamp":1761816522792,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.wneu.2022.04.042","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T19:20:19Z","timestamp":1650050419000},"page":"e127-e133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Distinctive MicroRNA Profiles in Serum of Patients with Neurofibromatosis Type 2: A Bioinformatic Exploratory Study"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6762-4980","authenticated-orcid":false,"given":"Takeshi","family":"Imura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5012-4659","authenticated-orcid":false,"given":"Kiyoharu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Mitsuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2022.04.042_bib1","first-page":"603","article-title":"A\u00a0clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.wneu.2022.04.042_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.wneu.2022.04.042_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/archdischild-2017-313154","article-title":"Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population","volume":"103","author":"Anand","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.wneu.2022.04.042_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jmg.2006.047753","article-title":"Mosaicism in neurofibromatosis type 2: an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification","volume":"44","author":"Evans","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2022.04.042_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.wneu.2022.04.042_bib6","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1097\/MAO.0000000000002557","article-title":"Contextualizing the modern epidemiology of neurofibromatosis type 2 in an era of heightened detection of sporadic vestibular schwannoma","volume":"41","author":"Dowling","year":"2020","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.wneu.2022.04.042_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","article-title":"Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas","volume":"54","author":"Antinheimo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2022.04.042_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.wneu.2022.04.042_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2176\/nmc.oa.2020-0106","article-title":"Social independence of patients with neurofibromatosis type 2 in Japan: analysis of a national registry of patients receiving medical expense subsidies, 2004-2013","volume":"60","author":"Okoshi","year":"2020","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2022.04.042_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.wneu.2017.07.036","article-title":"Population characteristics and progressive disability in neurofibromatosis type 2","volume":"106","author":"Iwatate","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.04.042_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0194599815573223","article-title":"Vestibular schwannoma excision in sporadic versus neurofibromatosis type 2 populations","volume":"153","author":"Mahboubi","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.wneu.2022.04.042_bib12","doi-asserted-by":"crossref","first-page":"106053","DOI":"10.1016\/j.clineuro.2020.106053","article-title":"Clinical and economic burden of neurofibromatosis type 2 in the United States","volume":"197","author":"Koo","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2022.04.042_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A\u00a0novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2022.04.042_bib14","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1101\/gad.194027.112","article-title":"Merlin\/ERM proteins establish cortical asymmetry and centrosome position","volume":"26","author":"Hebert","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2022.04.042_bib15","doi-asserted-by":"crossref","first-page":"12563","DOI":"10.1038\/s41598-020-69074-z","article-title":"Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas","volume":"10","author":"Pemov","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2022.04.042_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/curroncol28010071","article-title":"Rationale and design of BeatNF2 trial: a clinical trial to assess the efficacy and safety of bevacizumab in patients with neurofibromatosis type 2 related vestibular schwannoma","volume":"28","author":"Fujii","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.wneu.2022.04.042_bib17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0194599820954144","article-title":"Facial nerve Outcomes after vestibular schwannoma Microsurgical resection in neurofibromatosis type 2","volume":"164","author":"Sobieski","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.wneu.2022.04.042_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11060-021-03910-8","article-title":"Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis","volume":"156","author":"Tosi","year":"2022","journal-title":"J\u00a0Neurooncol"},{"issue":"Suppl","key":"10.1016\/j.wneu.2022.04.042_bib19","first-page":"143","article-title":"Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2","volume":"121","author":"Sun","year":"2014","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2022.04.042_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","article-title":"Spinal ependymomas in neurofibromatosis type 2: a retrospective analysis of 55 patients","volume":"14","author":"Plotkin","year":"2011","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.wneu.2022.04.042_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocn.2021.01.010","article-title":"Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: systematic review and case","volume":"86","author":"Snyder","year":"2021","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2022.04.042_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/neuonc\/nop010","article-title":"Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2","volume":"12","author":"Mautner","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.04.042_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00280-020-04229-3","article-title":"A\u00a0phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies","volume":"87","author":"Collier","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2022.04.042_bib24","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1158\/1078-0432.CCR-08-3011","article-title":"Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2","volume":"15","author":"Evans","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2022.04.042_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2022.04.042_bib26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.026","article-title":"Plasma levels of miR-125b-5p and miR-206 in acute ischemic stroke patients after recanalization treatment: a prospective observational study","volume":"28","author":"He","year":"2019","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2022.04.042_bib27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.wneu.2022.04.042_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","article-title":"Circulating microRNAs: biomarkers of disease","volume":"516","author":"Wu","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2022.04.042_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/HJH.0000000000003010","article-title":"Circulating miR-3656 induces human umbilical vein endothelial cell injury by targeting eNOS and ADAMTS13: a novel biomarker for hypertension","volume":"40","author":"Shi","year":"2022","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.wneu.2022.04.042_bib30","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/jcp.29367","article-title":"miR-188-5p suppresses cellular proliferation and migration via IL6ST: a potential noninvasive diagnostic biomarker for breast cancer","volume":"235","author":"Wang","year":"2020","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.wneu.2022.04.042_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.wneu.2022.04.042_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-014-2011-9","article-title":"The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals","volume":"392","author":"Chen","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.wneu.2022.04.042_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/gim.2013.114","article-title":"Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma","volume":"16","author":"Zhang","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.wneu.2022.04.042_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Kumar","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2022.04.042_bib35","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2022.04.042_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","article-title":"Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression","volume":"135","author":"Nishino","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2022.04.042_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2022.04.042_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13046-019-1190-3","article-title":"miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy","volume":"38","author":"Tang","year":"2019","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.wneu.2022.04.042_bib39","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.celrep.2016.02.075","article-title":"Merlin\/NF2-Lin28B-let-7 is a tumor-suppressive pathway that is cell-density dependent and Hippo Independent","volume":"14","author":"Hikasa","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.wneu.2022.04.042_bib40","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.00332-09","article-title":"Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway","volume":"29","author":"Saydam","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.wneu.2022.04.042_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ctrv.2014.05.004","article-title":"Systemic therapy in neurofibromatosis type 2","volume":"40","author":"Lim","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.wneu.2022.04.042_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/cr.2015.69","article-title":"Angiomotin binding-induced activation of Merlin\/NF2 in the Hippo pathway","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.wneu.2022.04.042_bib43","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1038\/s41598-019-39560-0","article-title":"miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFbeta, and Wnt signaling","volume":"9","author":"Mazzu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2022.04.042_bib44","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-16-2253","article-title":"miR-193b-regulated signaling networks serve as tumor suppressors in liposarcoma and promote adipogenesis in adipose-derived stem cells","volume":"77","author":"Mazzu","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2022.04.042_bib45","doi-asserted-by":"crossref","first-page":"e23239","DOI":"10.1002\/jcla.23239","article-title":"Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma","volume":"34","author":"Li","year":"2020","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.wneu.2022.04.042_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.2015.168","article-title":"MiR-320e is a novel prognostic biomarker in colorectal cancer","volume":"113","author":"Perez-Carbonell","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2022.04.042_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41419-020-2607-9","article-title":"Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1\/ERK1\/2 pathway","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.wneu.2022.04.042_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13046-021-02110-6","article-title":"DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-\u03baB signaling pathway by targeting TRAF1 in hepatocellular carcinoma","volume":"40","author":"Zhu","year":"2021","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.wneu.2022.04.042_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12894-021-00810-x","article-title":"MicroRNA-4429 suppresses proliferation of prostate cancer cells by targeting distal-less homeobox 1 and inactivating the Wnt\/beta-catenin pathway","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Urol"},{"key":"10.1016\/j.wneu.2022.04.042_bib50","first-page":"5555950","article-title":"miR-504 promoted Gastric cancer cell proliferation and inhibited cell Apoptosis by targeting RBM4","volume":"2021","author":"Zhang","year":"2021","journal-title":"J\u00a0Immunol Res"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022004909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022004909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:24:00Z","timestamp":1761816240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875022004909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":50,"alternative-id":["S1878875022004909"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2022.04.042","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive MicroRNA Profiles in Serum of Patients with Neurofibromatosis Type 2: A Bioinformatic Exploratory Study","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2022.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}